Keryx biopharmaceuticals inc (KERX)
Balance Sheet / Yearly
Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Dec'10
Assets
Current assets:
Cash and cash equivalents

41,146

49,458

60,087

93,526

113,999

140,527

90,909

111,810

132,172

155,796

170,531

200,290

102,208

131,289

168,836

74,284

84,132

91,994

105,257

55,696

67,738

55,879

87,343

14,677

20,248

21,100

-

35,252

-

-

-

Cash and cash equivalents

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

21,700

-

37,834

43,209

28,412

Short-term investment securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

11,508

34,101

44,991

49,665

-

-

24,294

-

-

-

6,012

9,212

4,211

9,263

9,316

100

Interest receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

48

151

136

195

-

156

226

-

-

-

38

67

7

64

7

-

Inventory

58,736

48,584

35,443

28,695

26,010

18,085

12,592

12,681

24,313

39,671

42,198

41,881

36,705

34,031

27,242

7,830

918

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts receivable, net

14,606

15,430

12,889

8,146

9,198

8,459

6,153

5,236

0

5,101

4,325

3,656

2,628

1,438

1,283

834

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Receivable from landlord

-

-

-

-

-

-

-

-

-

-

637

637

1,913

1,913

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other current assets

11,924

12,142

11,130

11,199

15,571

8,636

9,653

3,170

3,469

2,152

2,519

2,830

4,289

2,769

3,388

4,092

2,743

1,155

1,245

1,232

3,671

1,254

1,744

430

558

190

524

534

804

368

200

Total current assets

126,412

125,614

119,549

141,566

164,778

175,707

119,307

132,897

159,954

202,720

220,210

249,294

147,743

171,440

200,749

98,596

122,045

138,276

156,362

56,928

71,565

81,653

89,087

15,107

20,806

27,340

31,503

40,004

47,965

52,900

28,712

Property, plant and equipment, net

3,846

4,097

4,347

4,521

4,698

4,172

3,982

4,211

4,439

4,755

5,014

5,083

2,604

1,412

1,455

1,532

1,363

1,048

538

349

71

79

91

56

59

51

59

67

72

70

57

Goodwill

3,208

3,208

3,208

3,208

3,208

3,208

3,208

3,208

3,208

3,208

3,208

3,208

3,208

3,208

3,208

3,208

3,208

3,208

3,208

3,208

3,208

3,208

3,208

3,208

3,208

3,208

3,208

3,208

3,208

3,208

3,208

Other assets, net

18,318

12,732

13,018

9,577

1,138

1,102

1,199

1,111

1,024

1,024

1,100

1,100

1,099

1,099

307

292

292

362

217

281

221

163

163

198

198

209

209

209

209

209

137

Total assets

151,784

145,651

140,122

158,872

173,822

184,189

127,696

141,427

168,625

211,707

229,532

258,685

154,654

177,159

205,719

103,628

126,908

142,894

160,325

60,766

75,065

85,103

92,549

18,569

24,271

30,808

34,979

43,488

51,454

56,387

32,114

Liabilities and stockholders (deficit) equity
Current liabilities:
Accounts payable and accrued expenses

56,691

54,647

44,522

45,031

36,538

30,146

21,756

21,190

13,115

14,713

13,748

26,795

23,935

21,504

33,069

24,146

25,138

17,226

15,955

14,004

15,863

11,398

8,454

7,212

7,125

8,865

9,559

8,870

9,262

6,239

5,278

Accrued compensation and related liabilities

-

-

-

-

-

-

-

-

4,923

5,075

3,580

-

4,439

4,060

2,573

4,751

2,987

1,285

414

1,324

632

422

202

827

562

418

178

897

503

353

669

Deferred revenue

-

-

-

-

-

-

-

-

-

3,358

3,718

3,526

1,985

1,529

714

414

-

-

-

-

-

-

-

-

-

-

-

-

156

156

-

Derivative liability

-

-

-

-

-

-

-

-

-

-

48,693

46,686

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred lease incentive, current portion

244

244

244

244

244

244

244

244

244

244

244

244

244

244

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other current liabilities

165

158

152

145

138

131

124

117

-

15

93

355

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Liabilities of discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

245

Total current liabilities

57,100

55,049

44,918

45,420

36,920

30,521

22,124

21,551

18,282

23,405

70,076

77,606

30,603

27,337

36,356

29,311

28,125

18,511

16,369

15,328

16,495

11,820

8,656

8,039

7,687

9,283

9,737

9,767

9,921

6,748

6,192

Convertible senior notes

132,302

130,088

125,000

125,000

125,000

125,000

125,000

125,000

125,000

125,000

106,521

90,773

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loans payable

15,000

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred lease incentive, net of current portion

834

895

956

1,018

1,078

1,140

1,200

1,262

1,323

1,384

1,445

1,506

1,567

1,627

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred tax liability

0

0

0

635

930

909

890

870

-

-

-

790

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred tax liability

-

-

-

-

-

-

-

-

850

830

810

-

767

745

722

700

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Contingent equity rights

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,639

2,639

2,639

2,639

2,639

Other liabilities

767

811

856

894

932

970

1,007

1,040

1,181

1,234

1,285

1,076

647

311

99

133

75

78

41

38

-

12

24

36

-

11

24

35

-

12

35

Total liabilities

206,003

186,843

171,730

172,967

164,860

158,540

150,221

149,723

146,636

151,853

180,137

171,751

33,584

30,020

37,177

30,144

28,200

18,589

16,410

15,366

16,495

11,832

8,680

8,075

7,687

9,294

12,400

12,441

12,560

9,399

8,866

Commitments and contingencies

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

-

-

0

-

-

-

0

-

-

0

Stockholders (deficit) equity:
Preferred stock, $0.001 par value per share (5,000,000 shares authorized, no shares issued and outstanding)

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Common stock, $0.001 par value per share (230,000,000 shares authorized, 120,464,712 and 119,272,304 shares issued, 120,384,764 and 119,192,356 shares outstanding at September 30, 2018 and December 31, 2017, respectively)

120

120

120

119

119

119

108

106

106

106

106

105

105

105

104

93

92

92

91

83

82

82

82

72

72

72

71

71

71

70

62

Additional paid-in capital

1,004,349

1,000,381

988,447

984,681

977,309

970,498

835,838

827,053

823,554

819,723

764,613

761,189

757,541

752,865

747,392

624,606

609,546

599,854

597,051

485,014

480,517

479,567

478,807

403,387

402,849

402,304

401,866

401,220

400,692

398,540

365,307

Treasury stock, at cost, 79,948 shares

357

357

357

357

357

357

357

357

357

357

357

357

357

357

357

357

357

357

357

357

357

357

357

357

357

357

357

357

357

357

357

Accumulated deficit

-1,058,331

-1,041,336

-1,019,818

-998,538

-968,109

-944,611

-858,114

-835,098

-801,314

-759,618

-714,967

-674,003

-636,219

-605,474

-578,597

-550,858

-510,573

-475,284

-452,870

-439,340

-421,672

-406,021

-394,663

-392,608

-385,980

-380,505

-379,001

-369,887

-361,512

-351,265

-341,764

Total stockholders deficit

-54,219

-41,192

-31,608

-14,095

8,962

25,649

-22,525

-8,296

21,989

59,854

49,395

86,934

121,070

147,139

168,542

73,484

98,708

124,305

143,915

45,400

58,570

73,271

83,869

10,494

16,584

21,514

22,579

31,047

38,894

46,988

23,248

Total liabilities and stockholders deficit

151,784

145,651

140,122

158,872

173,822

184,189

127,696

141,427

168,625

211,707

229,532

258,685

154,654

177,159

205,719

103,628

126,908

142,894

160,325

60,766

75,065

85,103

92,549

18,569

24,271

30,808

34,979

43,488

51,454

56,387

32,114